@article{39e266c764094835beef6d85b2da824c,
title = "Hepatitis C virus entry inhibitors for optimally boosting direct-Acting antiviral-based treatments",
author = "Hirofumi Ohashi and Yoshiki Koizumi and Kento Fukano and Takaji Wakita and Perelson, {Alan S.} and Shingo Iwami and Koichi Watashi",
note = "Funding Information: This work was supported, in part, by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development (T.W. and K.W.); NIH Grants R01-AI028433, R01-AI078881, and R01-OD011095 (to A.S.P.); the Japan Science and Technology Agency (JST) Precursory Research for Embryonic Science and Technology program (S.I.); Japan Society for the Promotion of Science KAKENHI Grants 17H05819, 16H04845, 16K13777, 15KT0107, and 26287025 (to S.I.) and Grants 17H04085, 16KT0111, and 26460565",
year = "2017",
month = jun,
day = "6",
doi = "10.1073/pnas.1705234114",
language = "English",
volume = "114",
pages = "E4527--E4529",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
publisher = "National Academy of Sciences",
number = "23",
}
